Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
J.McNaughtonK
Patient FAQ Who should use IGF-1 LR3
Key facts about GLP-1-related gastroparesis: How it happens: GLP-1 drugs slow gastric emptying as part of their mechanism, but this effect becomes excessive in some people Whos at risk: Those with pre-existing digestive disorders, prior gastric surgery, long-standing diabetes, or elderly patients face higher risk Timeline: Symptoms can appear at any point during treatment, especially during dose increases Reversibility: Most cases improve after dose reduction or medication discontinuation, with recovery taking days to several months Management options: Dietary changes (smaller, low-fat meals), slower dose escalation, supportive medications, or temporary drug cessation Seek immediate medical attention for severe vomiting, dehydration signs, intense abdominal pain, or blood in vomit or stool
Although dosage recommendations vary from study to study, up to 2,000 milligrams (or two grams) per day seems safe and effective in the long-term
However, the rate of improvement slowed the largest changes occurred between weeks 4-8, with weeks 8-12 representing diminishing marginal gains
US$ 22.43
US$ 29.31
US$ 25.50
US$ 27.14
